Gloxitel-CH Tablet is a combination antihypertensive medication containing Telmisartan 40mg and Chlorthalidone 12.5mg, indicated for the management of hypertension. Telmisartan, an angiotensin II receptor blocker (ARB), selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, leading to decreased blood pressure. Chlorthalidone, a thiazide-like diuretic, promotes sodium and water excretion by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to volume reduction and further blood pressure lowering. The synergistic action of these agents provides effective and sustained antihypertensive control, reducing the risk of cardiovascular events such as stroke, myocardial infarction, and heart failure. Gloxitel-CH is typically prescribed when monotherapy is insufficient or when a combination therapy is preferred for enhanced efficacy and patient compliance. It is important to monitor renal function, electrolytes, and blood pressure regularly during treatment. Contraindications include hypersensitivity to either component, severe renal impairment, and anuria. Caution is advised in patients with hepatic dysfunction or electrolyte imbalances. Gloxitel-CH should be used under medical supervision, with dosage adjustments based on therapeutic response and tolerability.